These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15689292

  • 41. Metformin in polycystic ovary syndrome.
    Fisken RA.
    N Engl J Med; 2008 Apr 24; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
    [No Abstract] [Full Text] [Related]

  • 42. Effectiveness of insulin sensitizing drugs for polycystic ovary syndrome.
    Julson H.
    Am Fam Physician; 2007 Nov 01; 76(9):1308-9. PubMed ID: 18019873
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Expert Opin Ther Targets; 2009 Oct 01; 13(10):1205-26. PubMed ID: 19650762
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R.
    Clin Pharmacol Ther; 2006 Aug 01; 80(2):105-14. PubMed ID: 16890572
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Is metformin therapy for polycystic ovary syndrome safe during pregnancy?
    Brock B, Smidt K, Ovesen P, Schmitz O, Rungby J.
    Basic Clin Pharmacol Toxicol; 2005 Jun 01; 96(6):410-2. PubMed ID: 15910403
    [Abstract] [Full Text] [Related]

  • 49. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 50. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep 01; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 51. 'Off-label' use of metformin warranted.
    Robinson K.
    Adv Nurse Pract; 2001 Mar 01; 9(3):21. PubMed ID: 12400319
    [No Abstract] [Full Text] [Related]

  • 52. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of the American Society for Reproductive Medicine.
    Fertil Steril; 2004 Sep 01; 82 Suppl 1():S181-3. PubMed ID: 15363722
    [No Abstract] [Full Text] [Related]

  • 53. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK, Adya R, Chen J, Farhatullah S, Heutling D, Mitchell D, Lehnert H, Randeva HS.
    Cardiovasc Res; 2009 Aug 01; 83(3):566-74. PubMed ID: 19414528
    [Abstract] [Full Text] [Related]

  • 54. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH, Khalid R, Naru T, Rizvi J.
    J Obstet Gynaecol Res; 2008 Oct 01; 34(5):832-7. PubMed ID: 18834342
    [Abstract] [Full Text] [Related]

  • 55. Revisit of metformin treatment in polycystic ovarian syndrome.
    Lam PM, Cheung LP, Haines C.
    Gynecol Endocrinol; 2004 Jul 01; 19(1):33-9. PubMed ID: 15625771
    [Abstract] [Full Text] [Related]

  • 56. Metformin in the treatment of polycystic ovary syndrome.
    Motta DA.
    Curr Pharm Des; 2008 Jul 01; 14(21):2121-5. PubMed ID: 18691121
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [The use of oral antidiabetic drugs in the treatment of polycystic ovary syndrome].
    Tauchert S, Schröder AK, Ortmann O, Diedrich K, Weiss JM.
    Zentralbl Gynakol; 2003 Dec 01; 125(12):507-14. PubMed ID: 14755361
    [Abstract] [Full Text] [Related]

  • 59. [Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].
    Ma LK, Jin LN, Yu Q, Xu L.
    Zhonghua Fu Chan Ke Za Zhi; 2007 May 01; 42(5):294-7. PubMed ID: 17673038
    [Abstract] [Full Text] [Related]

  • 60. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF.
    Diabetes; 2008 Feb 01; 57(2):357-66. PubMed ID: 17977950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.